Written by Arvind Rajan, Co-Founder and CEO at Cricket Health

When we started Cricket Health three years ago, we wanted to take on hard problems in health care, and tackle a big challenge that would improve the lives of millions of people. And after talking with many people much smarter than we are, we realized there is no slice of health care more broken — and more in need of innovation — than kidney care.

Today we’re thrilled to announce a major step forward in our evolution: we have raised a $24 million Series A funding round from some truly outstanding investors, including Oak HC/FT, which led the round, and Cigna Corporation. We’re excited to partner with them to turn our vision into reality. Over the last three years we have been creating and validating a clinical intervention program for kidney disease, and building the best team to get us to this next step.

Kidney disease is incredibly common — and tragically overlooked. About 30 million Americans suffer from chronic kidney disease (CKD). But more than ninety percent of patients with CKD remain undiagnosed. Even among those who have advanced stages of the disease and who have lost more than seventy percent of their kidney function, close to sixty percent remain undiagnosed and two-thirds of people whose kidneys fail have an emergency start to dialysis in the hospital.

Lack of awareness of the disease is really only the beginning of the problem.

When patients do receive a kidney disease diagnosis, most patients get little to no intervention to slow the progression of the disease or to prepare for the path ahead. Instead, the kidney care industry is primarily focused on what happens after a patient’s kidneys have failed, and on getting patients onto in-center dialysis, a treatment that entails going to a center for hours a day, three days a week, when better alternatives exist for most patients.

At Cricket Health, we are building a very different kind of kidney care company. Our mission is to eliminate the burden of kidney disease.

We prioritize delaying kidney failure, ensuring prepared transitions, accelerating access to transplants, supporting patients on home dialysis modalities whenever possible, and providing empowered in-center dialysis for those where treatment at home is not a viable option. We put patients back in control of their lives with care that is cost-effective, keeps them healthy, and gives them hope for the future.

If we do this right, we can change millions of lives, allowing patients diagnosed with kidney disease to have more choices, more healthy days, and better care.

View the original LinkedIn post here